213 related articles for article (PubMed ID: 31580518)
1. The transmembrane protein LRIG2 increases tumor progression in skin carcinogenesis.
Hoesl C; Fröhlich T; Hundt JE; Kneitz H; Goebeler M; Wolf R; Schneider MR; Dahlhoff M
Mol Oncol; 2019 Nov; 13(11):2476-2492. PubMed ID: 31580518
[TBL] [Abstract][Full Text] [Related]
2. The transmembrane protein LRIG1 triggers melanocytic tumor development following chemically induced skin carcinogenesis.
Hoesl C; Fröhlich T; Posch C; Kneitz H; Goebeler M; Schneider MR; Dahlhoff M
Mol Oncol; 2021 Aug; 15(8):2140-2155. PubMed ID: 33786987
[TBL] [Abstract][Full Text] [Related]
3. Epidermal growth factor receptor-mediated activation of Stat3 during multistage skin carcinogenesis.
Chan KS; Carbajal S; Kiguchi K; Clifford J; Sano S; DiGiovanni J
Cancer Res; 2004 Apr; 64(7):2382-9. PubMed ID: 15059889
[TBL] [Abstract][Full Text] [Related]
4. ERBB3 is required for tumor promotion in a mouse model of skin carcinogenesis.
Dahlhoff M; Schäfer M; Muzumdar S; Rose C; Schneider MR
Mol Oncol; 2015 Nov; 9(9):1825-33. PubMed ID: 26194695
[TBL] [Abstract][Full Text] [Related]
5. Constitutive expression of erbB2 in epidermis of transgenic mice results in epidermal hyperproliferation and spontaneous skin tumor development.
Kiguchi K; Bol D; Carbajal S; Beltrán L; Moats S; Chan K; Jorcano J; DiGiovanni J
Oncogene; 2000 Aug; 19(37):4243-54. PubMed ID: 10980598
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of the prostaglandin E2 receptor EP2 results in enhanced skin tumor development.
Sung YM; He G; Hwang DH; Fischer SM
Oncogene; 2006 Sep; 25(40):5507-16. PubMed ID: 16607275
[TBL] [Abstract][Full Text] [Related]
7. KLK6 protease accelerates skin tumor formation and progression.
Khoury N; Zingkou E; Pampalakis G; Sofopoulos M; Zoumpourlis V; Sotiropoulou G
Carcinogenesis; 2018 Dec; 39(12):1529-1536. PubMed ID: 30137206
[TBL] [Abstract][Full Text] [Related]
8. Loss of DLX3 tumor suppressive function promotes progression of SCC through EGFR-ERBB2 pathway.
Bajpai D; Mehdizadeh S; Uchiyama A; Inoue Y; Sawaya A; Overmiller A; Brooks SR; Hasneen K; Kellett M; Palazzo E; Motegi SI; Yuspa SH; Cataisson C; Morasso MI
Oncogene; 2021 May; 40(21):3680-3694. PubMed ID: 33947961
[TBL] [Abstract][Full Text] [Related]
9. Ingenol-3-Angelate Suppresses Growth of Melanoma Cells and Skin Tumor Development by Downregulation of NF-κB-Cox2 Signaling.
Wang D; Liu P
Med Sci Monit; 2018 Jan; 24():486-502. PubMed ID: 29368698
[TBL] [Abstract][Full Text] [Related]
10. Forced expression of a constitutively active form of Stat3 in mouse epidermis enhances malignant progression of skin tumors induced by two-stage carcinogenesis.
Chan KS; Sano S; Kataoka K; Abel E; Carbajal S; Beltran L; Clifford J; Peavey M; Shen J; Digiovanni J
Oncogene; 2008 Feb; 27(8):1087-94. PubMed ID: 17700521
[TBL] [Abstract][Full Text] [Related]
11. Epidermal changes following application of 7,12-dimethylbenz(a)anthracene and 12-O-tetradecanoylphorbol-13-acetate to human skin transplanted to nude mice studied with histological species markers.
Graem N
Cancer Res; 1986 Jan; 46(1):278-84. PubMed ID: 3079587
[TBL] [Abstract][Full Text] [Related]
12. Cell Type-Specific p38δ Targeting Reveals a Context-, Stage-, and Sex-Dependent Regulation of Skin Carcinogenesis.
Kiss A; Koppel AC; Murphy E; Sall M; Barlas M; Kissling G; Efimova T
Int J Mol Sci; 2019 Mar; 20(7):. PubMed ID: 30934690
[TBL] [Abstract][Full Text] [Related]
13. Cutaneous changes during prolonged application of 12-O-tetradecanoylphorbol-13-acetate on mouse skin and residual effects after cessation of treatment.
Aldaz CM; Conti CJ; Gimenez IB; Slaga TJ; Klein-Szanto AJ
Cancer Res; 1985 Jun; 45(6):2753-9. PubMed ID: 3986807
[TBL] [Abstract][Full Text] [Related]
14. Squamous cell hyperplastic foci: precursors of cutaneous papillomas induced in SENCAR mice by a two-stage carcinogenesis regimen.
Binder RL; Johnson GR; Gallagher PM; Stockman SL; Sundberg JP; Conti CJ
Cancer Res; 1998 Oct; 58(19):4314-23. PubMed ID: 9766659
[TBL] [Abstract][Full Text] [Related]
15. Genetic deletion of TNFα inhibits ultraviolet radiation-induced development of cutaneous squamous cell carcinomas in PKCε transgenic mice via inhibition of cell survival signals.
Singh A; Singh A; Bauer SJ; Wheeler DL; Havighurst TC; Kim K; Verma AK
Carcinogenesis; 2016 Jan; 37(1):72-80. PubMed ID: 26586792
[TBL] [Abstract][Full Text] [Related]
16. Cyclooxygenase-dependent signaling is causally linked to non-melanoma skin carcinogenesis: pharmacological, genetic, and clinical evidence.
Müller-Decker K
Cancer Metastasis Rev; 2011 Dec; 30(3-4):343-61. PubMed ID: 22038018
[TBL] [Abstract][Full Text] [Related]
17. Soluble LRIG2 ectodomain is released from glioblastoma cells and promotes the proliferation and inhibits the apoptosis of glioblastoma cells in vitro and in vivo in a similar manner to the full-length LRIG2.
Xiao Q; Tan Y; Guo Y; Yang H; Mao F; Xie R; Wang B; Lei T; Guo D
PLoS One; 2014; 9(10):e111419. PubMed ID: 25353163
[TBL] [Abstract][Full Text] [Related]
18. Thrombospondin-2 overexpression in the skin of transgenic mice reduces the susceptibility to chemically induced multistep skin carcinogenesis.
Kunstfeld R; Hawighorst T; Streit M; Hong YK; Nguyen L; Brown LF; Detmar M
J Dermatol Sci; 2014 May; 74(2):106-15. PubMed ID: 24507936
[TBL] [Abstract][Full Text] [Related]
19. p38delta Mitogen-activated protein kinase is essential for skin tumor development in mice.
Schindler EM; Hindes A; Gribben EL; Burns CJ; Yin Y; Lin MH; Owen RJ; Longmore GD; Kissling GE; Arthur JS; Efimova T
Cancer Res; 2009 Jun; 69(11):4648-55. PubMed ID: 19458068
[TBL] [Abstract][Full Text] [Related]
20. Enhanced sensitivity to tumor growth and development in multistage skin carcinogenesis by transforming growth factor-alpha-induced epidermal growth factor receptor activation but not p53 inactivation.
Shibata MA; Ward JM; Green JE; Merlino G
Mol Carcinog; 1997 Mar; 18(3):160-70. PubMed ID: 9115586
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
